Working… Menu
Trial record 1 of 1 for:    NCT02410512
Previous Study | Return to List | Next Study

A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02410512
Recruitment Status : Completed
First Posted : April 7, 2015
Last Update Posted : March 1, 2021
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 22, 2019
Actual Study Completion Date : November 22, 2019